Actinium Pharmaceuticals Inc (ATNM)
8.96
+0.21
(+2.40%)
USD |
NYAM |
May 03, 16:00
8.915
-0.04
(-0.50%)
After-Hours: 20:00
Actinium Pharmaceuticals Shareholders Equity (Quarterly): 43.86M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 43.86M |
December 31, 2023 | 36.38M |
September 30, 2023 | 43.58M |
June 30, 2023 | 53.08M |
March 31, 2023 | 57.21M |
December 31, 2022 | 66.48M |
September 30, 2022 | 71.26M |
June 30, 2022 | 78.18M |
March 31, 2022 | 68.84M |
December 31, 2021 | 73.54M |
September 30, 2021 | 80.28M |
June 30, 2021 | 80.50M |
March 31, 2021 | 70.74M |
December 31, 2020 | 61.32M |
September 30, 2020 | 45.43M |
June 30, 2020 | 50.77M |
March 31, 2020 | 3.02M |
December 31, 2019 | 5.644M |
September 30, 2019 | 9.936M |
June 30, 2019 | 15.70M |
March 31, 2019 | 5.343M |
December 31, 2018 | 8.813M |
September 30, 2018 | 11.58M |
June 30, 2018 | 17.32M |
March 31, 2018 | 21.75M |
Date | Value |
---|---|
December 31, 2017 | 13.67M |
September 30, 2017 | 18.19M |
June 30, 2017 | 8.871M |
March 31, 2017 | 12.88M |
December 31, 2016 | 18.01M |
September 30, 2016 | 14.23M |
June 30, 2016 | 19.08M |
March 31, 2016 | 20.06M |
December 31, 2015 | 21.97M |
September 30, 2015 | 22.89M |
June 30, 2015 | 23.28M |
March 31, 2015 | 16.44M |
December 31, 2014 | -1.922M |
September 30, 2014 | 2.372M |
June 30, 2014 | 4.33M |
March 31, 2014 | -13.47M |
December 31, 2013 | -1.560M |
September 30, 2013 | 0.6043M |
June 30, 2013 | 1.915M |
March 31, 2013 | 0.5508M |
December 31, 2012 | 1.146M |
September 30, 2012 | -0.104M |
June 30, 2012 | -0.1003M |
March 31, 2012 | -0.094M |
December 31, 2011 | 0.992M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.02M
Minimum
Mar 2020
80.50M
Maximum
Jun 2021
50.79M
Average
55.14M
Median
Shareholders Equity (Quarterly) Benchmarks
Perspective Therapeutics Inc | 75.18M |
Eli Lilly and Co | 12.81B |
Cellectar Biosciences Inc | -1.356M |
Outlook Therapeutics Inc | -24.34M |
Bristol-Myers Squibb Co | 16.49B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 88.35M |
Total Liabilities (Quarterly) | 44.50M |